FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1514151000168100: Australian Black Triangle Scheme reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Dec 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4501271000168110 Australian Black Triangle Scheme reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4501281000168113 Australian Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501291000168111 Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501301000168112 BTS (Black Triangle Scheme) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501421000168113 <p>Supports the identification of AMT TPUU and CTPP concepts that are associated with medicines where reporting adverse events are encouraged under the Black Triangle Scheme. </p><p>This reference set can be used by prescribing and dispensing software vendors to identify medications where reporting of adverse events is encouraged under the Black Triangle Scheme.</p><p><span><b>Target client</b>: This reference set was developed by the National Clinical Terminology Service, based on information from the Therapeutic Goods Administration (TGA), to support the reporting of adverse events, and can be used by developers to assist with the identification of medicines associated with the Black Triangle Scheme.</span><br></p> en Definition Active Case sensitive Australian Medicines Terminology module


1411 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Black Triangle Scheme reference set Is a Reference sets for Medications true Inferred relationship Some
Black Triangle Scheme reference set Is a Simple type reference set true Inferred relationship Some
Black Triangle Scheme reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 494774926
Black Triangle Scheme reference set Developed by Australian Digital Health Agency true Inferred relationship Some 254185599

Members
Olumiant 4 mg tablet, 28, blister pack
Olumiant 4 mg tablet, 7, blister pack
Ongentys 50 mg capsule
Ongentys 50 mg capsule, 10, blister pack
Ongentys 50 mg capsule, 30, blister pack
Ongentys 50 mg capsule, 90, blister pack
Onpattro 10 mg/5 mL injection, 5 mL vial
Onpattro 10 mg/5 mL injection, 5 mL vial
Oxervate 20 microgram/mL eye drops, unit dose
Oxervate 20 microgram/mL eye drops, 7 x 1 mL unit doses, vial
Ozempic 1.34 mg/mL injection, 1 x 1.5 mL pen device
Ozempic 1.34 mg/mL injection, 1 x 3 mL pen device
Ozempic 1.34 mg/mL injection, 1.5 mL pen device
Ozempic 1.34 mg/mL injection, 3 mL pen device
Padcev 20 mg powder for injection, 1 vial
Padcev 20 mg powder for injection, 20 mg vial
Padcev 30 mg powder for injection, 1 vial
Padcev 30 mg powder for injection, 30 mg vial
Palynziq 10 mg/0.5 mL injection, 0.5 mL syringe
Palynziq 10 mg/0.5 mL injection, 0.5 mL syringe
Palynziq 2.5 mg/0.5 mL injection, 0.5 mL syringe
Palynziq 2.5 mg/0.5 mL injection, 0.5 mL syringe
Palynziq 20 mg/mL injection, 1 mL syringe
Palynziq 20 mg/mL injection, 1 mL syringe
Palynziq 20 mg/mL injection, 10 x 1 mL syringes
Paxlovid (4 x 150 mg tablets, 2 x 100 mg tablets), 5 x 6, blister packs
Paxlovid (4 x 150 mg tablets, 2 x 100 mg tablets), 6, blister pack
Paxlovid Nirmatrelvir 150 mg tablet
Paxlovid Ritonavir 100 mg tablet
Pifeltro 100 mg tablet
Pifeltro 100 mg tablet, 30, bottle
Piqray 150 mg tablet
Piqray 150 mg tablet, 28, blister pack
Piqray 150 mg tablet, 56, blister pack
Piqray 200 mg tablet
Piqray (14 x 50 mg tablets, 14 x 200 mg tablets), 28, blister pack
Piqray (28 x 50 mg tablets, 28 x 200 mg tablets), 56, blister pack
Piqray 200 mg tablet, 14, blister pack
Piqray 200 mg tablet, 28, blister pack
Piqray 50 mg tablet
Polivy 140 mg powder for injection, 1 vial
Polivy 140 mg powder for injection, 140 mg vial
Polivy 30 mg powder for injection, 1 vial
Polivy 30 mg powder for injection, 30 mg vial
Ponvory 20 mg tablet
Ponvory 20 mg tablet, 28, blister pack
Poteligeo 20 mg/5 mL injection, 5 mL vial
Poteligeo 20 mg/5 mL injection, 5 mL vial
Prevymis 240 mg/12 mL injection, 12 mL vial
Prevymis 240 mg/12 mL injection, 12 mL vial
Prevymis 240 mg tablet
Prevymis 240 mg tablet, 28, blister pack
Prevymis 480 mg/24 mL injection, 24 mL vial
Prevymis 480 mg/24 mL injection, 24 mL vial
Prevymis 480 mg tablet
Prevymis 480 mg tablet, 28, blister pack
Qarziba 20 mg/4.5 mL injection, 4.5 mL vial
Qarziba 20 mg/4.5 mL injection, 4.5 mL vial
Qinlock 50 mg tablet
Qinlock 50 mg tablet, 90, bottle
Radicava 30 mg/20 mL injection, 10 x 20 mL ampoules
Radicava 30 mg/20 mL injection, 20 mL ampoule
Rapivab 200 mg/20 mL injection, 20 mL vial
Rapivab 200 mg/20 mL injection, 3 x 20 mL vials
Reagila 1.5 mg capsule
Reagila 1.5 mg capsule, 10, blister pack
Reagila 1.5 mg capsule, 30, blister pack
Reagila 1.5 mg capsule, 60, blister pack
Reagila 1.5 mg capsule, 90, blister pack
Reagila 3 mg capsule
Reagila 3 mg capsule, 10, blister pack
Reagila 3 mg capsule, 30, blister pack
Reagila 3 mg capsule, 60, blister pack
Reagila 3 mg capsule, 90, blister pack
Reagila 4.5 mg capsule
Reagila 4.5 mg capsule, 30, blister pack
Reagila 4.5 mg capsule, 60, blister pack
Reagila 4.5 mg capsule, 90, blister pack
Reagila 6 mg capsule
Reagila 6 mg capsule, 30, blister pack
Reagila 6 mg capsule, 60, blister pack
Reagila 6 mg capsule, 90, blister pack
Refixia (1 x 1000 units vial, 1 x 4 mL inert diluent syringe), 1 pack
Refixia (1 x 2000 units vial, 1 x 4 mL inert diluent syringe), 1 pack
Refixia (1 x 500 units vial, 1 x 4 mL inert diluent syringe), 1 pack
Refixia (inert substance) diluent, 4 mL syringe
Refixia (nonacog beta pegol 1000 units) powder for injection, 1000 units vial
Refixia (nonacog beta pegol 2000 units) powder for injection, 2000 units vial
Refixia (nonacog beta pegol 500 units) powder for injection, 500 units vial
Regkirona 960 mg/16 mL injection, 16 mL vial
Regkirona 960 mg/16 mL injection, 16 mL vial
Revestive (28 x 5 mg vials, 28 x 0.5 mL inert diluent syringes), 1 pack
Revestive (inert substance) diluent, 0.5 mL syringe
Revestive (teduglutide 5 mg) powder for injection, 5 mg vial
Rinvoq 15 mg modified release tablet
Rinvoq 15 mg modified release tablet, 28, blister pack
Rinvoq 15 mg modified release tablet, 7, blister pack
Rinvoq 30 mg modified release tablet
Rinvoq 30 mg modified release tablet, 28, blister pack
Rinvoq 30 mg modified release tablet, 7, blister pack
Rinvoq 45 mg modified release tablet

Start Previous Page 10 of 15 Next End


Reference Sets

Reference set descriptor

Back to Start